Copyright
©The Author(s) 2025.
World J Diabetes. May 15, 2025; 16(5): 104482
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.104482
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.104482
Table 1 Comparison of general information and biochemical indices among four groups
Indicator | NC group | NUA1b group | MUA1b group | CUA1b group | F/H/χ2 | P value |
Age, months | 112 (106, 116) | 119 (77, 150) | 123 (79, 155) | 131 (82, 145) | 0.005 | 0.995 |
Family history | 65 (30, 35) | 50 (23, 27) | 32 (15, 17) | 20 (11, 9) | 0.489 | 0.783 |
BMI, kg/m² | 16.79 (15.01, 19.54) | 16.40 (15.38, 18.95) | 15.70 (14.75, 17.25) | 17.15 (14.73, 19.65) | 3.76 | 0.153 |
SBP, mmHg | 104 ± 11 | 106 ± 13 | 108 ± 10 | 109 ± 15 | 0.473 | 0.625 |
DBP, mmHg | 66 (59, 73) | 64 (60, 72) | 65 (60, 70) | 67 (60, 78) | 0.758 | 0.471 |
Blood urea, mmol/L | 4.03 (3.45, 4.68) | 4.39 (3.86, 5.88) | 4.90 (4.08, 6.43) | 5.20 (4.14, 7.97)a | 3.348 | 0.187 |
Blood creatinine, μmol/L | 37 (34, 42) | 35 (30, 45) | 33 (26, 44) | 41 (35, 48)c | 2.006 | 0.14 |
C-reactive protein, mg/L | 4.1 (0.1, 5.7) | 3.4 (0.0, 5.2) | 2.4 (0.7, 4.4) | 5.0 (2.3, 11.2) | 1.002 | 0.059 |
ALT, U/L | 29 (11, 37) | 32 (24, 41) | 36 (27, 51) | 40 (22, 49) | 0.177 | 0.838 |
AST, U/L | 32 (20, 36) | 31 (22, 46) | 34 (26, 44) | 41 (19, 53) | 0.007 | 0.993 |
Total cholesterol, mmol/L | 3.89 (3.34, 4.39) | 4.31 (3.79, 5.08)a | 4.91 (4.50, 5.41)a,b | 5.68 (4.19, 6.65)a,b | 8.708 | 0.013 |
Triglycerides, mmol/L | 0.91 (0.71, 1.30) | 1.05 (0.72, 2.15)a | 1.70 (1.19, 2.91)a,b | 2.83 (1.86, 3.79)a,b,c | 20.631 | < 0.001 |
HDL, mmol/L | 1.35 (1.18, 1.53) | 1.25 (1.07, 1.54) | 1.23 (1.00, 1.47) | 1.31 (1.06, 1.44) | 0.244 | 0.784 |
LDL, mmol/L | 2.06 (1.76, 2.51) | 1.94 (1.60, 2.61) | 2.98 (2.20, 3.50)a,b | 2.44 (2.00, 3.31)b | 6.593 | 0.002 |
C-peptide, nmol/L | 0.80 (0.55, 1.10) | 0.25 (0.09, 0.48)a | 0.24 (0.15, 0.29)a | 0.20 (0.12, 0.32)a | 76.498 | < 0.001 |
Insulin, mU/L | 13.50 (8.50, 19.75) | 2.46 (1.05, 5.62)a | 2.05 (1.07, 3.63)a | 2.79 (0.85, 4.22)a | 100.35 | < 0.001 |
eGFR, mL/minute/1.73 m² | 194.36 ± 44.67 | 202.63 ± 74.54 | 207.92 ± 54.58 | 164.64 ± 33.71a,b,c | 3.376 | 0.038 |
UACR, mg/g | 8 (4, 14) | 6 (3, 17) | 76 (46, 158)a,b | 565 (366, 820)a,b,c | 85.232 | < 0.001 |
HbA1c, % | 5.0 (4.7, 5.3) | 9.9 (7.0, 13.2)a | 12.9 (11.4, 16.0)a,b | 14.8 (13.4, 15.3)a,b | 19.238 | < 0.001 |
Systemic inflammation index, 109/L | 278 (188.89, 331.47) | 366.76 (254.14, 458.30)a | 331.12 (202.53, 999.19)a | 1459.92 (1214.27, 2838.30)a,b,c | 37.354 | < 0.001 |
Neutrophil-to-lymphocyte ratio | 1.12 (0.69, 1.46) | 1.42 (1.02, 1.95)a | 1.80 (1.17, 2.59)a | 5.54 (2.58, 9.55)a,b,c | 24.207 | < 0.001 |
Platelet-to-lymphocyte ratio | 83.17 (59.83, 105.49) | 104.05 (79.23, 115.83)a | 113.51 (85.76, 149.95)a | 130.13 (118.99, | 20.53 | < 0.001 |
- Citation: Cao LF, Xu QB, Yang L. Systemic immune indicators for predicting renal damage in newly diagnosed type 1 diabetic children. World J Diabetes 2025; 16(5): 104482
- URL: https://www.wjgnet.com/1948-9358/full/v16/i5/104482.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i5.104482